CAMK1D and cancer: Since NCI‐60 cancer cell lines with higher MPS1 mRNA levels, but not CAMK1D, showed a weak association with sensitivity to VU‐0365114 treatment (Fig. 10E), further investigation was conducted to examine the role of MPS1 in the anticancer activity of VU‐0365114.